📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: QSAM Biosciences

1.1 - Company Overview

QSAM Biosciences Logo

QSAM Biosciences

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of nuclear medicines for the treatment of cancer and related diseases and conditions.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to QSAM Biosciences

ImmunoGen Logo

ImmunoGen

HQ: United States Website
  • Description: Provider of antibody-based anticancer therapeutics using TAP, ELAHERE for platinum-resistant ovarian cancer; investigational IMGN632 for acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm; mirvetuximab soravtansine (monotherapy, with bevacizumab or carboplatin) for platinum-sensitive ovarian cancers; and IMGN151 for recurrent endometrial and high-grade serous epithelial ovarian, primary peritoneal, or fallopian tube cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ImmunoGen company profile →
Delcath Systems Logo

Delcath Systems

HQ: United States Website
  • Description: Provider of interventional oncology therapies for metastatic liver cancer, including HEPZATO KIT for adult patients with metastatic uveal melanoma using a hepatic delivery system; the CHEMOSAT Hepatic Delivery System for melphalan for percutaneous hepatic perfusion to treat liver cancers; and Percutaneous Hepatic Perfusion, a minimally invasive procedure delivering high-dose chemotherapy directly to the liver while isolating the organ from the body’s circulatory system.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Delcath Systems company profile →
Ikena Oncology Logo

Ikena Oncology

HQ: United States Website
  • Description: Provider of novel biomarker-driven targeted cancer therapies, advancing a pipeline focused on the Hippo and RAS signaling pathways to address cancer growth, spread, and resistance.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ikena Oncology company profile →
TORL Biotherapeutics Logo

TORL Biotherapeutics

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical research and development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full TORL Biotherapeutics company profile →
OnKure Therapeutics Logo

OnKure Therapeutics

HQ: United States Website
  • Description: Provider of next-generation oncology precision medicines targeting validated cancer drivers, developed by a clinical-stage biopharma.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OnKure Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for QSAM Biosciences

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to QSAM Biosciences

2.2 - Growth funds investing in similar companies to QSAM Biosciences

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for QSAM Biosciences

4.2 - Public trading comparable groups for QSAM Biosciences

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to QSAM Biosciences

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About QSAM Biosciences

What does QSAM Biosciences do?

QSAM Biosciences is a provider of nuclear medicines for the treatment of cancer and related diseases and conditions.

Who are QSAM Biosciences's competitors?

QSAM Biosciences's competitors and similar companies include ImmunoGen, Delcath Systems, Ikena Oncology, TORL Biotherapeutics, and OnKure Therapeutics.

Where is QSAM Biosciences headquartered?

QSAM Biosciences is headquartered in United States.

How many employees does QSAM Biosciences have?

QSAM Biosciences has 1,000 employees 🔒.

When was QSAM Biosciences founded?

QSAM Biosciences was founded in 2010 🔒.

What sector and industry vertical is QSAM Biosciences in?

QSAM Biosciences is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for QSAM Biosciences

Who are the top strategic acquirers in QSAM Biosciences's sector and industry

Top strategic M&A buyers and acquirers in QSAM Biosciences's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for QSAM Biosciences?

Top strategic M&A buyers groups and sectors for QSAM Biosciences include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in QSAM Biosciences's sector and industry vertical

Which are the top PE firms investing in QSAM Biosciences's sector and industry vertical?

Top PE firms investing in QSAM Biosciences's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in QSAM Biosciences's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in QSAM Biosciences's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in QSAM Biosciences's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to QSAM Biosciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in QSAM Biosciences's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for QSAM Biosciences?

The key public trading comparables and valuation benchmarks for QSAM Biosciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for QSAM Biosciences for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for QSAM Biosciences with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in QSAM Biosciences's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for QSAM Biosciences with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in QSAM Biosciences's' sector and industry vertical?

Access recent funding rounds and capital raises in QSAM Biosciences's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for QSAM Biosciences